202112 May
Bio-CFD Launches the World’s First Medical Flow Simulation Platform with a Flagship Application to Help Patients with Neurovascular Disease
Type
New Products
Source
Pr
Summary

Wilmington, DE, May 12, 2021 --( NeuroCFD is the flagship application of Bio-CFD Inc., a U.S.-based medtech startup working to harness the power of Computational Fluid Dynamics (CFD) to advance personalized medicine and bring its benefits to the bed side. “Our workflow allows medical users to learn, adapt and carry out CFD simulations easily and at scale with minimal template-based setup routine,” says Dr. Khalid Saqr, Bio-CFD’s founder and CEO. Now, NeuroCFD’s innovative workflow seamlessly integrates data from imaging modalities and blood picture to help patients with neurovascular disease receive personalized care and management. “CFD has been serving the medical research community for more than three decades, now it’s the right time to bring its power to help patients in daily clinical settings,” says Dr. Sherif Rashad, a neurosurgeon who uses NeuroCFD to personalize diagnosis and management of carotid stenosis patients.CFD simulations requires parallel computing infrastructure with extensive CPU, memory and storage resources to provide accurate and useful information. Now, NeuroCFD’s innovative workflow seamlessly integrates data from imaging modalities and blood picture to help patients with neurovascular disease receive personalized care and management.About Bio-CFDBio-CFD is world’s first Computational Fluid Dynamics (CFD) platform for medicine and life sciences.

Classifications
  • AI & Machine learning